Royal Bank of Canada’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-32
Closed 7619
2024
Q2
$0 Sell
32
-165
-84% -$281 ﹤0.01% 7655
2024
Q1
$1K Sell
197
-4,785
-96% -$8.99K ﹤0.01% 6900
2023
Q4
$3K Buy
4,982
+3,475
+231% +$4.77K ﹤0.01% 6764
2023
Q3
$6K Buy
1,507
+601
+66% +$2.76K ﹤0.01% 6589
2023
Q2
$5K Buy
+906
New +$5.31K ﹤0.01% 6694

Other funds holding OCEA

Royal Bank of Canada's OCEA Position: Q3 2024 in Review

Royal Bank of Canada sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q3 2024, closing a stake of 32 shares.

Royal Bank of Canada first reported a position in OCEA in Q2 2023 and held it in 5 quarters. The position peaked at $6K in Q3 2023. 21 funds tracked by Wall St. Rank hold OCEA as of Q3 2024.

  • Royal Bank of Canada reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 32 Ocean Biomedical, Inc. Common Stock shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 5 quarters.
  • Royal Bank of Canada's Ocean Biomedical, Inc. Common Stock position peaked at $6K in Q3 2023.
  • 21 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.